Genetics of Response to ECT, TMS, Ketamine and Esketamine
Franklin C, Altinay M, Bailey K, Bhati M, Carr B, Conroy S, Khurshid K, McDonald W, Mickey B, Murrough J, Nestor S, Nickl‐Jockschat T, Reti I, Sanacora G, Trapp N, Viswanath B, Wright J, Zandi P, Potash J. Genetics of Response to ECT, TMS, Ketamine and Esketamine. American Journal Of Medical Genetics Part B Neuropsychiatric Genetics 2025, 198: 88-102. PMID: 40525674, PMCID: PMC12230785, DOI: 10.1002/ajmg.b.33038.Peer-Reviewed Original ResearchGenome-wide association studiesSingle nucleotide polymorphismsTreatment responseEffects of variantsElectroconvulsive therapyGenetic predictors of treatment responseTreatment modalitiesAssociation studiesCandidate genesFactors affecting treatment responseAssociated with treatment responseResponse to available treatmentsGene studiesNucleotide polymorphismsTreatment-resistant mood disordersGenetic predictors of responseTreatment-resistant depressionPredictors of treatment responsePredictors of responseGroup of patientsGenesTranscranial magnetic stimulationGeneticsGenetic predictorsClinical response
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply